Skip to main content
Signal8

AgPlenus Announces Significant Progress in Its Fungicide Discovery Programs Targeting New Modes of Action, with Activity Against Resistant Septoria and Additional Fungal Pathogens

$EVGNPress releaseNov 17, 2026, 7:00 AM ETRead the release

Evogene's subsidiary AgPlenus reported progress in two fungicide discovery programs targeting novel modes of action against Septoria tritici blotch, a major wheat disease. Active molecules generated by its ChemPass AI for Ag platform showed fungicidal activity including against resistant Septoria strains, reduced disease by 75% in plant tissue assays, and were independently corroborated by an external research organization.

Key figures

Septoria market opportunity
€1.2 billion
Disease reduction in plant tissue assays
75%
Historic european wheat fungicide share stb
70%

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.